Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Structure-Activity Relationships and Drug Design01:28

Structure-Activity Relationships and Drug Design

1.6K
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
1.6K
Dosage Regimens: Designs and Approaches01:28

Dosage Regimens: Designs and Approaches

191
Designing a dosage regimen, which refers to the manner of drug administration, is a complex process involving the selection of drug dose, route, and frequency. This process is underpinned by pharmacokinetic parameters derived from tests and population averages. These parameters are then tailored to patient-specific variables such as diagnosis, demographics, and allergy status. Once therapy commences, therapeutic response monitoring is critical and achieved through clinical and physical...
191
Drug Discovery: Overview01:26

Drug Discovery: Overview

10.8K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
10.8K
Determination of Multiple Dosing Parameters: Loading and Maintenance Doses01:25

Determination of Multiple Dosing Parameters: Loading and Maintenance Doses

138
A loading dose is an essential pharmacological strategy to rapidly achieve the target plasma drug concentration necessary for an immediate therapeutic effect. This approach is especially critical for drugs characterized by slow absorption or extended half-lives, where delaying therapeutic plasma levels could compromise treatment outcomes. By administering a loading dose, clinicians ensure a prompt onset of drug action, even for agents with complex pharmacokinetic profiles.Achieving steady-state...
138
Dosage Regimen Designs: Nomograms and Tabulations01:23

Dosage Regimen Designs: Nomograms and Tabulations

112
Nomograms and tabulations are vital tools used by clinicians to design accurate and individualized dosage regimens. These instruments provide a straightforward method for adjusting dosages based on individual patient characteristics, including age, weight, and physiological condition. The foundation of a drug's nomogram is population pharmacokinetic data collected and analyzed using specific models. This data simplifies complex equations, presenting them diagrammatically or tabularly for easy...
112
Drug Concentration Versus Time Correlation01:15

Drug Concentration Versus Time Correlation

1.8K
The plasma drug concentration-time curve is a crucial tool in pharmacokinetics, representing the drug's concentration in plasma at different time intervals post-administration. This curve illustrates the drug's journey from absorption into the systemic circulation, distribution to body tissues, and eventual elimination through excretion or biotransformation.
Two pivotal parameters are the minimum effective concentration (MEC) and the minimum toxic concentration (MTC). The MEC is the...
1.8K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Commentary on the fundamentals and development of artificial intelligence models in the life sciences and best research practices.

Journal of computer-aided molecular design·2026
Same author

Explainable artificial intelligence reveals divergent learning in pharmacophore-based hierarchical pooling graph neural networks.

Scientific reports·2026
Same author

Categorization of Protein Kinases by Combining Data from Cell Biology and Medicinal Chemistry Enables Further Evaluation and Differentiation of the Understudied Kinome.

Journal of medicinal chemistry·2026
Same author

Explainable artificial intelligence for molecular design in pharmaceutical research.

Chemical science·2026
Same author

Transformer Learning in Sequence-Based Drug Design Depends on Compound Memorization and Similarity of Sequence-Compound Pairs.

Molecular informatics·2026
Same author

A meta-learning framework to mitigate negative transfer in transfer learning applicable to drug design.

Scientific reports·2025

Related Experiment Video

Updated: Dec 24, 2025

Efficient Sampling of Genetically Encoded Biosensor Design Space Enabled with a Design of Experiments and Automation Workflow
08:58

Efficient Sampling of Genetically Encoded Biosensor Design Space Enabled with a Design of Experiments and Automation Workflow

Published on: October 17, 2025

472

From SAR Diagnostics to Compound Design: Development Chronology of the Compound Optimization Monitor (COMO) Method.

Dimitar Yonchev1, Martin Vogt1, Jürgen Bajorath1

  • 1Department of Life Science Informatics Bonn-Aachen International Center for Information Technology, Rheinische Friedrich-Wilhelms-Universität Bonn, Endenicher Allee 19c, D-53115, Bonn, Germany.

Molecular Informatics
|April 14, 2020
PubMed
Summary
This summary is machine-generated.

Medicinal chemistry optimization faces challenges in predicting success. A new computational method, the compound optimization monitor (COMO), assesses analog saturation and structure-activity relationships to aid decision-making in drug discovery projects.

Keywords:
SAR progressionactivity predictionanalog designanalog serieschemical saturationchemical spacecompound neighborhoodsoptimizationstructure-activity relationships (SARs)virtual analogs

More Related Videos

Applying Cheminformatics to Develop a Structure Searchable Database of Analytical Methods
05:34

Applying Cheminformatics to Develop a Structure Searchable Database of Analytical Methods

Published on: June 6, 2025

1.5K
Author Spotlight: Accelerating Discovery in Microporous Material Chemistry
07:20

Author Spotlight: Accelerating Discovery in Microporous Material Chemistry

Published on: October 6, 2023

4.2K

Related Experiment Videos

Last Updated: Dec 24, 2025

Efficient Sampling of Genetically Encoded Biosensor Design Space Enabled with a Design of Experiments and Automation Workflow
08:58

Efficient Sampling of Genetically Encoded Biosensor Design Space Enabled with a Design of Experiments and Automation Workflow

Published on: October 17, 2025

472
Applying Cheminformatics to Develop a Structure Searchable Database of Analytical Methods
05:34

Applying Cheminformatics to Develop a Structure Searchable Database of Analytical Methods

Published on: June 6, 2025

1.5K
Author Spotlight: Accelerating Discovery in Microporous Material Chemistry
07:20

Author Spotlight: Accelerating Discovery in Microporous Material Chemistry

Published on: October 6, 2023

4.2K

Area of Science:

  • Medicinal Chemistry
  • Computational Chemistry
  • Drug Discovery

Background:

  • Compound optimization in drug discovery relies heavily on expert knowledge, making project progress difficult to predict.
  • Existing methods for decision support in hit-to-lead and lead optimization are limited.
  • Assessing the likelihood of success for analog series is crucial for efficient resource allocation.

Purpose of the Study:

  • To introduce a computational methodology for assessing compound optimization projects.
  • To provide decision support for continuing or discontinuing analog series development.
  • To enhance lead optimization diagnostics through predictive capabilities.

Main Methods:

  • Developed a computational methodology integrating chemical saturation of analog series and structure-activity relationship (SAR) progression.
  • The methodology's endpoint is the Compound Optimization Monitor (COMO).
  • COMO provides diagnostics for compound design and activity prediction.

Main Results:

  • The Compound Optimization Monitor (COMO) was developed as a tool for lead optimization.
  • COMO combines chemical saturation assessment with SAR progression analysis.
  • The tool extends diagnostics to compound design and predicts activity.

Conclusions:

  • The Compound Optimization Monitor (COMO) offers a novel computational approach to medicinal chemistry optimization.
  • COMO aids in decision-making by assessing project success probabilities.
  • This methodology supports lead optimization campaigns by providing predictive insights and design guidance.